Microchimeric Cells, Sex Chromosome Aneuploidies and Cancer

Pathology and Oncology Research

Volumn 21, Issue 4, 2015, Pages 1157-1165

  Korkmaz, Deniz Taştemir ^a   Demirhan, Osman ^b   Abat, Deniz ^b   Demirberk, Bülent ^c   Tunç, Erdal ^b   Kuleci, Sedat ^b  

^a ADIYAMAN UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

^c Adana Mental and Nervous diseases Hospital   (Turkey)

Author keywords

Bladder cancer; Lung cancer; Microchimeric cells; Sex chromosome aneuploidies

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANEUPLOIDY; ARTICLE; BLADDER CANCER; BLOOD ANALYSIS; CANCER RADIOTHERAPY; CARCINOGENESIS; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CONTROLLED STUDY; FEMALE; FETUS CELL; HUMAN; HUMAN TISSUE; IMMUNITY; KARYOTYPE 47,XXY; MAJOR CLINICAL STUDY; MALE; MICROCHIMERIC CELL; MICROCHIMERISM; MONOSOMY X; SMALL CELL LUNG CANCER; VERY ELDERLY; X CHROMOSOME; Y CHROMOSOME; GENETICS; MIDDLE AGED; NEOPLASM; SEX CHROMOSOME;

ADULT; AGED; ANEUPLOIDY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SEX CHROMOSOMES;

EID: 84940447737     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-015-9934-7     Document Type: Article

References (53)

1. Scheike O, Visfeldt J, Petersen B (1973) Male breast cancer. 3. Breast cancer in association with Klinefelter syndrome. Acta Path Microbiol Scand A 81(3):352–358
2. Krasna I, Lee H, Sinilow ML, Sciorra P, Eierman L (1992) Risk of malignancy in bilateral streak gonads: the role of the Y chromosome. J Pediatr Surg 27:1376–1380
3. Jacobs PA, Maloney V, Cooke R, Crolla JA, Ashworth A, Swerdlow AJ (2013) Male breast cancer, age and sex chromosome aneuploidy. Br J Cancer 108:959–963
4. Riske CB, Morgan R, Ondreyco S, Sandberg AA (1994) X and Y chromosome loss as sole abnormality in acute non-lymphocytic leukemia (ANLL). Cancer Genet Cytogenet 72:44–47
5. Khosrotehrani K, Bianchi DW (2003) Fetal cell microchimerism: helpful or harmful to the parous woman? Curr Opin Obstet Gynecol 15:195–199
6. O’Donoghue K, Chan J, de la Fuente J, Kennea N, Sandison A, Anderson JR, Roberts IAG, Fisk NM (2004) Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem cell trafficking in pregnancy. Lancet 364:179–182
7. Sawicki JA (2008) Fetal microchimerism and cancer. Cancer Res 68:9567–9569
8. Grigorova M, Lyman RC, Caldas C, Edwards PAW (2005) Chromosome abnormalities in 10 lung cancer cell lines of the NCI-H series analyzed with spectral karyotyping. Cancer Genet Cytogenet 162:1–9
9. Watters AD, Going JJ, Grigor KM, Bartlett JM (2002) Progression to detrusor-muscle invasion in bladder carcinoma is associated with polysomy of chromosomes 1 and 8 in recurrent pTa/pT1 tumors. Eur J Cancer 38:1593–1599
10. Ribal MJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofre C, Palou J, Gelabert A, Villavicencio H (2004) Chromosomal high-polysomies predict tumor progression in T1 transitional cell carcinoma of the bladder. Eur Urol 45:593–599
11. Ross MT, Grafham DV, Coffey AJ, Scherer S, McLay K, Muzny D, Platzer M, Howell GR, Burrows C, Bird CP, Frankish A, Lovell FL, Howe KL, Ashurst JL, Fulton RS, Sudbrak R, Wen G, Jones MC, Hurles ME, Andrews TD et al (2005) The DNA sequence of the human X chromosome. Nature 434:325–337
12. Piao Z, Malkhosyan SR (2002) Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis. Gene Chromosome Cancer 33:262–269
13. Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC, Koi M (1997) Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Gene Chromosome Cancer 20:234–242
14. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ (1999) Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Gene Chromosome Cancer 26:346–354
15. Sandberg AA (1983) The X chromosome in human neoplasia, including sex chromatin and congenital conditions with X-chromosome anomalies. In: Sandberg AA (ed) Cytogenetics of the mammalian X chromosome, part B: X chromosome anomalies and their clinical manifestations. Alan R. Liss, New York, pp 459–498
16. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP (1994) Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145:624–630
17. Wang MG, Zakut R, Yi H, Rosenberg S, McBride OW (1994) Localization of the MAGE1 gene encoding a human melanoma antigen to chromosome Xq28. Cytogenet Cell Genet 67:116–119
18. Gough NM, Gearing DP, Nicola NA, Baker E, Pritchard M, Callen DF, Sutherland GR (1990) Localization of the human GM-CSF receptor gene to the X-Y pseudoautosomal region. Nature 345:734–736
19. Beck TW, Huleihel M, Gunnell M, Bonner TI, Rapp UR (1987) The complete coding sequence of the human A-raf-1 oncogene and transforming activity of ahuman A-raf carrying retrovirus. Nucleic Acids Res 15:595–609
20. Rao VN, Huebner K, Isobe M, ar-Rushdi A, Croce CM, Reddy ES (1989) Elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science 244:66–70
21. Noguchi T, Mattei MG, Oberle I, Planche J, Imbert J, Pelassy C, Birg F, Birnbaum D (1987) Localization of the mcf.2 transforming sequence to the X chromosome. EMBO J 6:1301–1307
22. Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL (1999) Chromosomal clues to the development of prostate tumors. Prostate 38:303–312
23. Jordan JJ, Hanlon AL, Greenberg RE, Al-Saleem TI, Tricoli JV (2001) Loss of the short arm of the Y chromosome in human prostate carcinoma. Cancer Genet Cytogenet 124:122–126
24. Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R, Kagan J, Naylor SL (2005) The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in a thymic nude mice. Gene Chromosome Cancer 44:365–372
25. Teixeira MR, Pandis N, Dietrich CU, Reed W, Andersen J, Qvist H, Heim S (1998) Chromosome banding analysis of gynecomastias and breast carcinomas in men. Gene Chromosome Cancer 23:16–20
26. Rudas M, Schmidinger M, Wenzel C, Okamoto I, Budinsky A, Fazeny B, Marosi C (2000) Karyotypic findings in two cases of male breast cancer. Cancer Genet Cytogenet 121:190–193
27. Wallrapp C, Hahnel S, Boeck W, Soder A, Mincheva A, Lichter P, Leder G, Gansauge F, Sorio C, Scarpa A, Gress TM (2001) Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. Int J Cancer 91:340–344
28. Powell I, Tyrkus M, Kleer E (1990) Apparent correlation of sex chromosome loss and disease course in urothelial cancer. Cancer Genet Cytogenet 50:97–101
29. Mohanty D (2004) Sex chromosome loss and malignancy: Does a relationship established?.Indian. J Hum Genet 10:3–4
30. Betz J, Meloni AM, Sandberg AA (1996) FISH studies on the Y chromosome in male urinary cells. Cancer Genet Cytogenet 88:155–157
31. Sauter G, Moch H, Wagner U, Novotna H, Gasser TC, Mattarelli G, Mihatsch MJ, Waldman FM (1995) Y chromosome loss detected by FISH in bladder cancer. Cancer Genet Cytogenet 82:163–169
32. Sauter G, Moch H, Gasser TC, Mihatsch MJ, Waldman FM (1995) Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer. Cytometry 21:40–46
33. Pierre RV, Hoagland HC (1972) Age-associated aneuploidy: Loss of Y chromosome from human bonemarrow cells with aging. Cancer 30:889–894
34. Sakurai M, Sandberg AA (1976) The chromosomes and causation of human caner and leukemia XVIII. The missing Y in acute myeloblastic leukemia and Ph1-positive chronic myelocytic leukemia [CML]. Cancer 38:762–769
35. United Kingdom Cancer Cytogenetics Group (UK CCG) (1992) Loss of the Y chromosome from normal and neoplastic bonemarrows. Gene Chromosome Cancer 5:83–88
36. Mertens F, Johansson B, Hoglund M, Mitelman F (1997) Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 57:2765–2780
37. El-Naggar A, Dinh M, Tucker SL, Swanson D, Steck K, Vielh P (1999) Numerical chromosomal changes in DNA hypodiploid solid tumors: restricted loss and gain of certain chromosomes. Cytometry 37:107–112
38. Nilbert M, Heim S (1990) Uterine leiomyoma cytogenetics. Gene Chromosome Cancer 2:3–13
39. Mark J, Havel G, Grepp C, Dahlenfors R, Wedell B (1990) Chromosomal patterns in human benign uterine leiomyomas. Cancer Genet Cytogenet 44:1–13
40. Vanni R, Lecca U, Faa G (1991) Uterine leiomyoma cytogenetics. II. Report of forty cases. Cancer Genet Cytogenet 53:247–256
41. Witek A, Skalba P, Zieba M (2001) Pituitary tumor in a woman with a 47, XXX karyotype–case report. Med Sci Monit 7:304–330
42. Gul D, Akin R, Kismet E (2003) Neuroblastoma in a patient with 47, XXX karyotype. Cancer Genet Cytogenet 146:84–85
43. Swerdlow AJ, Schoemaker MJ, Higgins C, Wright AF, Jacobs PA, UK Clinical Cytogenetics Group (2005) Cancer incidence and mortality in patients with Klinefelter’s syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210
44. Brown CJ, Greally JM (2003) A stain upon the silence: genes escaping X inactivation. Trends Genet 19:432–438
45. Nelson JL (2001) Microchimerism: expanding new horizon in human health or incidental remnant of pregnancy? Lancet 358:2011–2012
46. Gadi VK, Nelson JL (2007) Fetal microchimerism in women with breast cancer. Cancer Res 67:9035–9038
47. O’Donoghue K, Sultan HA, Al-Allaf FA, Anderson JR, Wyatt-Ashmead J, Fisk NM (2008) Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy. Reprod Biomed Online 16:382–390
48. Li L, Neaves WB (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66:4553–4557
49. Cha DH, Khosrotehrani K, Kim Y, Stroh H, Bianchi DW, Johnson CL (2003) Cervical cancer and microchimerism. Obstet Gynecol 102:774–781
50. Kamper-Jørgensen M, Biggar RJ, Tjønneland A, Hjalgrim H, Kroman N, Rostgaard K, Stamper CL, Olsen A, Andersen AM, Gadi VK (2012) Opposite effects of microchimerism on breast and colon cancer. Eur J Cancer 48:2227–2235
51. Srivatsa B, Srivatsa S, Johnson KL, Bianchi DW (2003) Maternal cell microchimerism in newborn tissues. J Pediatr 142:31–35
52. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP (1997) PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822–882
53. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW (2001) Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358:2034–2038